Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8287546rdf:typepubmed:Citationlld:pubmed
pubmed-article:8287546lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8287546lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:8287546lifeskim:mentionsumls-concept:C0074302lld:lifeskim
pubmed-article:8287546lifeskim:mentionsumls-concept:C0302933lld:lifeskim
pubmed-article:8287546lifeskim:mentionsumls-concept:C2924614lld:lifeskim
pubmed-article:8287546lifeskim:mentionsumls-concept:C0037806lld:lifeskim
pubmed-article:8287546lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:8287546lifeskim:mentionsumls-concept:C1708110lld:lifeskim
pubmed-article:8287546pubmed:issue1lld:pubmed
pubmed-article:8287546pubmed:dateCreated1994-2-24lld:pubmed
pubmed-article:8287546pubmed:abstractTextWe developed an assay for the direct determination of selenium in serum with a Perkin-Elmer Model 4100ZL Zeeman atomic absorption spectrometer and Ag-Cu-Mg modifier. We used this assay to analyze concanavalin A-bound selenoprotein (CABSP) in human serum after concanavalin A (ConA) affinity chromatography. The CABSP was identified as a single-chain glycoprotein of 57.3 kDa. Carbohydrate units were N- and O-linked to the protein. The selenium moiety was selenocysteine. Total selenium, glutathione peroxidase (GPX; EC 1.11.1.9), ConA-bound selenium (CABS), and alpha 1-acid glycoprotein (AAG) were determined in normal subjects and patients with various pathological conditions. CABS accounted for 44.1% +/- 6.3% of total selenium in sera from normal subjects and 46.5% +/- 3.9% to 55.1% +/- 8.1% in sera from patients with a variety of diseases. Total selenium in serum was well correlated with serum CABS (r = 0.860), but not with serum GPX activity (r = 0.117), for all patients studied. Serum CABS increased in normal subjects after selenium supplementation. Serum CABSP did not behave as an acute-phase reactant, compared with AAG.lld:pubmed
pubmed-article:8287546pubmed:languageenglld:pubmed
pubmed-article:8287546pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8287546pubmed:citationSubsetIMlld:pubmed
pubmed-article:8287546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8287546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8287546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8287546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8287546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8287546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8287546pubmed:statusMEDLINElld:pubmed
pubmed-article:8287546pubmed:monthJanlld:pubmed
pubmed-article:8287546pubmed:issn0009-9147lld:pubmed
pubmed-article:8287546pubmed:authorpubmed-author:Van LenteFFlld:pubmed
pubmed-article:8287546pubmed:authorpubmed-author:DaherRRlld:pubmed
pubmed-article:8287546pubmed:issnTypePrintlld:pubmed
pubmed-article:8287546pubmed:volume40lld:pubmed
pubmed-article:8287546pubmed:ownerNLMlld:pubmed
pubmed-article:8287546pubmed:authorsCompleteYlld:pubmed
pubmed-article:8287546pubmed:pagination62-70lld:pubmed
pubmed-article:8287546pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:meshHeadingpubmed-meshheading:8287546-...lld:pubmed
pubmed-article:8287546pubmed:year1994lld:pubmed
pubmed-article:8287546pubmed:articleTitleConcanavalin A-bound selenoprotein in human serum analyzed by graphite furnace atomic absorption spectrometry.lld:pubmed
pubmed-article:8287546pubmed:affiliationDepartment of Chemistry, Cleveland State University, OH 44115.lld:pubmed
pubmed-article:8287546pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8287546lld:pubmed